abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

이야기

2018년 5월 3일

USA: Rise in opioids deaths leads state officials to file claims against drug firms and distributors

The opioid crisis has continued to grow in the United States leading to an increased number of pharmaceutical companies involved in litigation for their responsibility in the dubious marketing and distribution of opioid products. This Story compiles developments about the legal accountability related to pharmaceutical companies' role in creating and exacerbating the opioid epidemic in the United States.

타임라인